{"id":950564,"date":"2026-04-10T15:51:58","date_gmt":"2026-04-10T19:51:58","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/"},"modified":"2026-04-10T15:51:58","modified_gmt":"2026-04-10T19:51:58","slug":"adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/","title":{"rendered":"ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations \u2013 Lowey Dannenberg, P.C."},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, April  10, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wyWimQDee6aJU5uRMHjULRgwyVMvN_JXWg321G2XQUJoql5GJ_OHOo_Gp9rGMbiNjdCtVurU3cP8HzKMWuzB9lo5-xb55q6fLNW1t2IEr5U=\" rel=\"nofollow\" target=\"_blank\"><strong>Lowey Dannenberg P.C.<\/strong><\/a>, a top complex litigation law firm, is investigating ADMA Biologics (NASDAQ: ADMA) (\u201cADMA Biologics\u201d or the \u201cCompany\u201d) for potential violations of the federal securities laws.<\/p>\n<p align=\"justify\">On March 24, 2026, Culper Research, an investigative research firm, published a report titled \u201cADMA Biologics Inc (ADMA): Channel Stuffing, an Undisclosed Related Party Distributor, and -3% Real Growth in 2025 vs. +20% Reported.\u201d The report revealed, among other things, that in 2025 ADMA Biologics induced one of its distributors to \u201cstock excess ASCENIV by offering rebates and extended payment terms in order to meet order expectations.\u201d This allegedly allowed ADMA Biologics to book revenue and \u201creport[] growth that was never there.\u201d According to Culper Research, had ADMA Biologics not engaged in this alleged channel stuffing scheme, it would have experienced revenue declines of 3% in 2025 instead of the reported 20% growth.<\/p>\n<p align=\"justify\">\u201cOur investigation concerns whether the company and its executives provided investors with accurate and complete information about the company,\u201d said attorney Andrea Farah, Lowey Dannenberg, P.C. partner and head of the firm\u2019s securities practice.<\/p>\n<p align=\"justify\">If you suffered a loss of more than $50,000 in ADMA Biologics securities, and wish to participate, or learn more about your eligibility, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zqcvjeeWqEx8hPXG4QRp-gv7bApE2iwXWeQmEQGAAHZvJoyNfan_8kaEufXhqHD_8Y9bOtjsrqKEtBRxXeSk53X7oeBzKAes0jFu9z8vlek=\" rel=\"nofollow\" target=\"_blank\"><strong>click here<\/strong><\/a>, or contact our attorneys Andrea Farah (afarah@lowey.com) at (914)733-7256 or Vincent R. Cappucci Jr. (vcappucci@lowey.com) at (914)733-7278. To submit additional details, you can also visit our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Md6U6sLmsLmGbLsLhmDFiMpJ2rJMa4FFSU5OXRSYHuFC6A_qFRwTiBrbephjrMcpmZvKOTivcJzXD41Sp7ZTmROdyfFw5uSMGZpD4dAHb3OQPIX2vFsw7gpZbNIf6lmk\" rel=\"nofollow\" target=\"_blank\"><strong>firm\u2019s website here<\/strong><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About Lowey Dannenberg<\/strong>\n      <\/p>\n<p align=\"justify\">Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.<\/p>\n<p>\n        <strong>Contact<\/strong>\n      <\/p>\n<p>Lowey Dannenberg P.C.<br \/>44 South Broadway, Suite 1100<br \/>White Plains, NY 10601<br \/>Tel: (914) 733-7256<br \/>Email:\u00a0 investigations@lowey.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4Nzg1MyM3NTMwMTI0IzIxOTQ1MzQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NWRjMTg5ZTAtMjk0Ny00YmQ3LWEwZTMtMGFjNGExNjQwZmViLTEyMDYwODctMjAyNi0wNC0xMC1lbg==\/tiny\/Lowey-Dannenberg-P-C-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a top complex litigation law firm, is investigating ADMA Biologics (NASDAQ: ADMA) (\u201cADMA Biologics\u201d or the \u201cCompany\u201d) for potential violations of the federal securities laws. On March 24, 2026, Culper Research, an investigative research firm, published a report titled \u201cADMA Biologics Inc (ADMA): Channel Stuffing, an Undisclosed Related Party Distributor, and -3% Real Growth in 2025 vs. +20% Reported.\u201d The report revealed, among other things, that in 2025 ADMA Biologics induced one of its distributors to \u201cstock excess ASCENIV by offering rebates and extended payment terms in order to meet order expectations.\u201d This allegedly allowed ADMA Biologics to book revenue and \u201creport[] growth that was never there.\u201d According to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations \u2013 Lowey Dannenberg, P.C.&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-950564","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations \u2013 Lowey Dannenberg, P.C. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations \u2013 Lowey Dannenberg, P.C. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a top complex litigation law firm, is investigating ADMA Biologics (NASDAQ: ADMA) (\u201cADMA Biologics\u201d or the \u201cCompany\u201d) for potential violations of the federal securities laws. On March 24, 2026, Culper Research, an investigative research firm, published a report titled \u201cADMA Biologics Inc (ADMA): Channel Stuffing, an Undisclosed Related Party Distributor, and -3% Real Growth in 2025 vs. +20% Reported.\u201d The report revealed, among other things, that in 2025 ADMA Biologics induced one of its distributors to \u201cstock excess ASCENIV by offering rebates and extended payment terms in order to meet order expectations.\u201d This allegedly allowed ADMA Biologics to book revenue and \u201creport[] growth that was never there.\u201d According to &hellip; Continue reading &quot;ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations \u2013 Lowey Dannenberg, P.C.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-10T19:51:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4Nzg1MyM3NTMwMTI0IzIxOTQ1MzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations \u2013 Lowey Dannenberg, P.C.\",\"datePublished\":\"2026-04-10T19:51:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\\\/\"},\"wordCount\":318,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4Nzg1MyM3NTMwMTI0IzIxOTQ1MzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\\\/\",\"name\":\"ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations \u2013 Lowey Dannenberg, P.C. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4Nzg1MyM3NTMwMTI0IzIxOTQ1MzQ=\",\"datePublished\":\"2026-04-10T19:51:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4Nzg1MyM3NTMwMTI0IzIxOTQ1MzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4Nzg1MyM3NTMwMTI0IzIxOTQ1MzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations \u2013 Lowey Dannenberg, P.C.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations \u2013 Lowey Dannenberg, P.C. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/","og_locale":"en_US","og_type":"article","og_title":"ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations \u2013 Lowey Dannenberg, P.C. - Market Newsdesk","og_description":"NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a top complex litigation law firm, is investigating ADMA Biologics (NASDAQ: ADMA) (\u201cADMA Biologics\u201d or the \u201cCompany\u201d) for potential violations of the federal securities laws. On March 24, 2026, Culper Research, an investigative research firm, published a report titled \u201cADMA Biologics Inc (ADMA): Channel Stuffing, an Undisclosed Related Party Distributor, and -3% Real Growth in 2025 vs. +20% Reported.\u201d The report revealed, among other things, that in 2025 ADMA Biologics induced one of its distributors to \u201cstock excess ASCENIV by offering rebates and extended payment terms in order to meet order expectations.\u201d This allegedly allowed ADMA Biologics to book revenue and \u201creport[] growth that was never there.\u201d According to &hellip; Continue reading \"ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations \u2013 Lowey Dannenberg, P.C.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-10T19:51:58+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4Nzg1MyM3NTMwMTI0IzIxOTQ1MzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations \u2013 Lowey Dannenberg, P.C.","datePublished":"2026-04-10T19:51:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/"},"wordCount":318,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4Nzg1MyM3NTMwMTI0IzIxOTQ1MzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/","name":"ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations \u2013 Lowey Dannenberg, P.C. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4Nzg1MyM3NTMwMTI0IzIxOTQ1MzQ=","datePublished":"2026-04-10T19:51:58+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4Nzg1MyM3NTMwMTI0IzIxOTQ1MzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4Nzg1MyM3NTMwMTI0IzIxOTQ1MzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-nasdaq-adma-investigated-for-potential-federal-securities-laws-violations-lowey-dannenberg-p-c\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations \u2013 Lowey Dannenberg, P.C."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=950564"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950564\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=950564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=950564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=950564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}